---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-003920"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:44:36.485600+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals appoints Ira Strassberg as CFO and Treasurer effective March 15, 2022

## Summary
- Ira Strassberg appointed CFO and Treasurer effective March 15, 2022; had been financial consultant since August 2021.
- Compensation: $400k base salary, $200k target bonus, and options for 425k shares at $3.10/share vesting over two years.
- Previous roles include Deputy CFO of Cantor Fitzgerald, CFO of Cantor Commercial Real Estate, and senior roles at KPMG.
- Severance: one-year base salary plus prorated bonus if terminated without cause or for good reason; accelerated vesting.

## SEC filing metadata
- accession: 0001558370-22-003920
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000155837022003920/0001558370-22-003920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000155837022003920/nrxp-20220315x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-003920
- JSON: https://secwatch.observer/filing/0001558370-22-003920.json
- Plain text: https://secwatch.observer/filing/0001558370-22-003920.txt

## Key facts
- Executive change
  Ira Strassberg was appointed as Chief Financial Officer and Treasurer at NRX Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: On March 15, 2022, the Board of Directors of NRx Pharmaceuticals, Inc. (the “Company”) appointed Mr. Ira Strassberg, 55, to serve as Chief Financial Officer (CFO) and Treasurer of the Company effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1719406/000155837022003920/0001558370-22-003920-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.